Across TCGA pan-cancer cohorts, TRAJ33 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TRAJ33’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where TRAJ33 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRAJ33 is over-expressed in tumor.
BRCA, STAD, and LUAD are the cancer types where TRAJ33 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRAJ33 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.